Stocks / Biotech

BEAMBiotech

Beam Therapeutics Inc.
$24.211d -4.5%5d -17.3%settled close · 2026-09-10
Mkt cap $2.4B (9/8)β 2.0252w $19.88–38Shares 101.9MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 2020Emp. 511HQ Cambridge, MAbeamtx.com
Who’s talkingIdea Scout · free

Who’s talking about BEAM

No tracked investor commentary on BEAM yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 2 Nov 2026

Confirmed date · consensus EPS -1.16. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where BEAM’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 23 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-09
2026-09-08
2026-09-04
2026-08-26
2026-08-25
2026-08-21
2026-08-19
2026-07-07
2026-07-06
2026-07-02
2026-06-30
2026-06-24
2026-05-27
2026-05-11
2026-04-28
2026-04-17
2026-04-16
2026-04-15
2026-04-14
2026-04-13
2026-03-27
2026-03-26
2026-03-25
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on BEAM is in this morning’s Brief. Get The Brief — $20/mo →